BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16309380)

  • 1. Sensitive immunoassays for the autoantibodies reacting against citrullinated carboxy-terminal telopeptides of type I and type II collagens in patients with rheumatoid arthritis.
    Koivula MK; Ramberg J; Aman S; Karjalainen A; Hakala M; Risteli J
    Clin Chem Lab Med; 2005; 43(12):1400-5. PubMed ID: 16309380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are there autoantibodies reacting against citrullinated peptides derived from type I and type II collagens in patients with rheumatoid arthritis?
    Koivula MK; Aman S; Karjalainen A; Hakala M; Risteli J
    Ann Rheum Dis; 2005 Oct; 64(10):1443-50. PubMed ID: 16162901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory characteristics of citrullinated telopeptides of type I and II collagens for autoantibody binding in patients with rheumatoid arthritis.
    Koivula MK; Aman S; Alasaarela E; Karjalainen A; Hakala M; Risteli J
    Rheumatology (Oxford); 2006 Nov; 45(11):1364-9. PubMed ID: 16632481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies binding to citrullinated telopeptides of type I and type II collagens and to mutated citrullinated vimentin synergistically predict the development of seropositive rheumatoid arthritis.
    Koivula MK; Heliövaara M; Rissanen H; Palosuo T; Knekt P; Immonen H; Risteli J
    Ann Rheum Dis; 2012 Oct; 71(10):1666-70. PubMed ID: 22419777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Separate and overlapping specificities in rheumatoid arthritis antibodies binding to citrulline- and homocitrulline-containing peptides related to type I and II collagen telopeptides.
    Turunen S; Hannonen P; Koivula MK; Risteli L; Risteli J
    Arthritis Res Ther; 2015 Jan; 17(1):2. PubMed ID: 25573503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies binding to citrullinated telopeptide of type II collagen and to cyclic citrullinated peptides predict synergistically the development of seropositive rheumatoid arthritis.
    Koivula MK; Heliövaara M; Ramberg J; Knekt P; Rissanen H; Palosuo T; Risteli J
    Ann Rheum Dis; 2007 Nov; 66(11):1450-5. PubMed ID: 17472989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated immunoassays for the autoantibodies to carbamylated or citrullinated telopeptides of type I and II collagens.
    Häyrynen J; Kärkkäinen M; Kononoff A; Arstila L; Elfving P; Niinisalo H; Savolainen E; Kautiainen H; Risteli J; Kaipiainen-Seppänen O; Koivula MK
    Clin Chem Lab Med; 2015 Aug; 53(9):1375-80. PubMed ID: 25389994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.
    Snir O; Widhe M; von Spee C; Lindberg J; Padyukov L; Lundberg K; Engström A; Venables PJ; Lundeberg J; Holmdahl R; Klareskog L; Malmström V
    Ann Rheum Dis; 2009 May; 68(5):736-43. PubMed ID: 18635594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of citrullinated collagen type II and its antibodies in rheumatoid arthritis].
    Tian X; Bi LQ; Li ZG
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(33):2334-8. PubMed ID: 17156630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ureido group-specific antibodies are induced in rabbits immunized with citrulline- or homocitrulline-containing antigens.
    Turunen S; Koivula MK; Risteli L; Risteli J
    Autoimmunity; 2016 Nov; 49(7):459-465. PubMed ID: 27098309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients.
    Snir O; Widhe M; Hermansson M; von Spee C; Lindberg J; Hensen S; Lundberg K; Engström A; Venables PJ; Toes RE; Holmdahl R; Klareskog L; Malmström V
    Arthritis Rheum; 2010 Jan; 62(1):44-52. PubMed ID: 20039432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmunity to citrullinated type II collagen in rheumatoid arthritis.
    Yoshida M; Tsuji M; Kurosaka D; Kurosaka D; Yasuda J; Ito Y; Nishizawa T; Yamada A
    Mod Rheumatol; 2006; 16(5):276-81. PubMed ID: 17039307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiplex analyses of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritis.
    Brink M; Hansson M; Mathsson L; Jakobsson PJ; Holmdahl R; Hallmans G; Stenlund H; Rönnelid J; Klareskog L; Rantapää-Dahlqvist S
    Arthritis Rheum; 2013 Apr; 65(4):899-910. PubMed ID: 23310951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncoupling of collagen II metabolism in newly diagnosed, untreated rheumatoid arthritis is linked to inflammation and antibodies against cyclic citrullinated peptides.
    Christensen AF; Hørslev-Petersen K; Christgau S; Lindegaard HM; Lottenburger T; Junker K; Hetland ML; Stengaard-Pedersen K; Jacobsen S; Ellingsen T; Andersen LS; Hansen I; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen AJ; Tarp U; Pødenphant J; Heegaard NH; Vestergaard A; Jurik AG; Ostergaard M; Junker P
    J Rheumatol; 2010 Jun; 37(6):1113-20. PubMed ID: 20436079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The autoantibody response to cyclic citrullinated collagen type II peptides in rheumatoid arthritis.
    Liang B; Ge C; Lönnblom E; Lin X; Feng H; Xiao L; Bai J; Ayoglu B; Nilsson P; Nandakumar KS; Zhao M; Holmdahl R
    Rheumatology (Oxford); 2019 Sep; 58(9):1623-1633. PubMed ID: 30892636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies against the CB10 fragment of type II collagen in rheumatoid arthritis.
    Cook AD; Gray R; Ramshaw J; Mackay IR; Rowley MJ
    Arthritis Res Ther; 2004; 6(5):R477-83. PubMed ID: 15380047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
    Charni N; Juillet F; Garnero P
    Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity and specificity of autoantibodies binding to citrullinated carboxyterminal telopeptides of types I and II collagens in an early arthritis series.
    Koivula MK; Savolainen E; Kaipiainen-Seppänen O; Kautiainen H; Luosujärvi R; Hakala M; Risteli J
    Rheumatology (Oxford); 2008 May; 47(5):656-9. PubMed ID: 18356174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].
    Us D; Gülmez D; Hasçelik G
    Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not?
    Vannini A; Cheung K; Fusconi M; Stammen-Vogelzangs J; Drenth JP; Dall'Aglio AC; Bianchi FB; Bakker-Jonges LE; van Venrooij WJ; Pruijn GJ; Zendman AJ
    Ann Rheum Dis; 2007 Apr; 66(4):511-6. PubMed ID: 16984940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.